Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Marinac received her PhD in Public Health from the UC San Diego/San Diego State University Joint Doctoral Program in 2016 and completed her postdoctoral training in the Division of Population Sciences at Dana-Farber Cancer Institute and the Department of Epidemiology at Harvard T.H. Chan School of Public Health. She joined the faculty in the Division of Population Sciences in 2019. Her research is focused on identifying and testing new cancer early detection and prevention strategies.
I have an interest in the impact of modifiable lifestyle factors on cancer etiology and survival and I am committed to applying the knowledge gained from my research to the development and testing of novel cancer screening, prevention, and interception strategies. Much of my current work focuses on the prevention and control of multiple myeloma, which is an understudied and incurable plasma cell malignancy. I am particularly interested in identifying novel prevention strategies for individuals diagnosed with monoclonal gammopathy of undetermined significance and smoldering multiple myeloma, which are premalignant blood conditions that progress to overt multiple myeloma in a subset of patients for reasons that are poorly understood.
Dana-Farber Cancer Institute450 Brookline AvenueDana 1133Boston, MA 02215Get Directions